13th edition

Format
HYBRID

December 3rd & 4th, 2024

IN-PERSON | LILLE, FR

December 11th& 12th 2024

ONLINE MEETINGS

BioFIT General Commissioner Etienne Vervaecke discusses BioFIT 2016 agenda

Dealing with key issues in Life Sciences, BioFIT 2016’s conference programme promises a varied and rich agenda featuring the latest opinions on trending topics.

Discover our interview with Etienne Vervaecke, General Commissioner for BioFIT 2016 and Managing Director of Eurasanté/NHL Cluster.

 

BioFIT Steering Committee met last month, what did you discuss?

Our goal is to surpass the expectations of BioFIT’s visitors, to update the event programme with up-to-the-minute content. We focused on enhancing the conference programme and creating new meeting opportunities. This is a very exciting time for the Steering Committee.

What’s new in the BioFIT 2016 programme?

An exciting opportunity will be the Slam Sessions, which are designed to give young researchers and academic spinoffs the chance to publicly pitch their research and business projects to a jury of experts. These slams are an opportunity to exchange ideas and receive feedback from experienced professionals. In addition, the presenters will improve their public speaking skills and benefit from the audience’s participation. This is the way to involve the entire BioFIT community and also advice future project leaders.

The BioFIT programme is more varied this year: what will change?

We will keep the sessions scheduled for the two-day conference programme which will focus on three themes:

  • Track 1: Showcasing best practices in collaborative research,
  • Track 2: Highlighting key issues in licensing and tech transfer and
  • Track 3: Discussing early stage innovation funding.

However, the sessions will be reworked to be more interactive, with formats such as expert forums, workshops, break-out sessions and panels.

We look forward to discovering BioFIT in Lille on 30th November and 1st December 2016. BioFIT is the only place to meet the right people for early stage Life Sciences innovation.

Sponsors

Contact

Vincent Tavernier

Scroll to Top
  • No products in the cart.